KLOW Stack 80 mg — Third-Party Test Results
Manufacturer: LeoLab™ RX
Sample: KLOW Stack 80 mg
Date: 06 OCT 2025
On September 30, 2025, LeoLab RX submitted a KLOW Stack 80 mg (Batch KW10057) sample for independent third-party analysis by Janosik Analytical, a trusted laboratory specializing in pharmaceutical and peptide quality control. The sample was received on October 3, 2025, and the testing was registered under Task Number #81948. The analysis evaluated the mass content of each peptide component within the stack to verify composition accuracy and labeling precision.
🔬Test Summary
-
Stack Name: KLOW Stack
-
Batch Number: KW10057
-
Total Nominal Quantity: 80 mg
-
Analysis Conducted: 06 OCT 2025
✅ Review and Analysis
The analysis performed by Janosik Analytical confirmed that the measured masses of all components closely match the expected formulation, validating the accuracy and consistency of the KLOW Stack’s composition. Each peptide—GHK-Cu, BPC-157, TB-500, and KPV—was individually quantified, confirming the presence of all declared components in the correct proportions.
-
GHK-Cu: 52.92 mg — the main component, precisely quantified.
-
BPC-157: 10.80 mg — accurately measured for consistency.
-
TB-500 (TB4): 10.31 mg — aligns with labeling.
-
KPV: 13.78 mg — confirmed via comment section in the report.
These results indicate that the KLOW Stack is formulated with a high degree of precision, suitable for research applications requiring accurate peptide ratios.
Measured Component Masses
